{"slug":"semax-cognition","verification":{"valid":true,"entries":2,"head":"0747fb149dc2be29da66c633c15dffaf5fcb51effcc061f47d1f0b70c509d93b"},"energy":{"passes":2,"tokens_in":33532,"tokens_out":2965,"tokens_total":36497,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"0747fb149dc2be29da66c633c15dffaf5fcb51effcc061f47d1f0b70c509d93b"},"provenance":[{"ts":"2026-06-30T00:14:01.966Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Cognition\nSlug: semax-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other laye","response":"{\n  \"slug\": \"semax-cognition\",\n  \"title\": \"Semax for Cognition: BDNF Pathways, Human Data, and Repair vs Fatigue\",\n  \"body\": \"## What's breaking down\\n\\nCognitive performance relies on ongoing neural repair. When BDNF levels drop, synaptic plasticity slows. Attention and short-term memory suffer. Dopamine system stress from stimulants or chronic load adds fatigue. These layers compound: reduced BDNF limits new connections, while ongoing stress accelerates wear on existing ones. The result is persistent brain fog, slower learning, and weaker recall even after rest. Repair pathways fall behind degeneration.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\\n\\nIf BDNF signaling is low, the peptide's studied effects on hippocampal expression and protein levels align with supporting plasticity. If fatigue follows high cognitive demand, the focus on neural maintenance rather than stimulation fits the repair frame.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural / cognitive layer directly through BDNF-related pathways. No siblings in scope here.\\n\\n## What the evidence actually shows\\n\\nHuman data: Two small pilot studies in healthy volunteers. One with 24 subjects showed increased resting fMRI signal in the default mode network rostral subcomponent after intranasal 1% Semax (total 1.2 mg) versus placebo (Lebedeva et al, 2018, via Alzheimer's Drug Discovery Foundation review). Another in fatigued healthy males after an 8-hour shift reported 71% accuracy on a memory test versus 41% in controls following a single 16 mcg/kg intranasal dose; effects lasted up to 24 hours (referenced in m","tokens_in":33532,"tokens_out":2965,"cost":0,"prev":"genesis","hash":"9aa53781d34b17c66eb4ac7b0f4eb8566d7bc2fc10bf75cf84162d09f52e7418"},{"ts":"2026-07-17T02:41:52.556Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-cognition","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9aa53781d34b17c66eb4ac7b0f4eb8566d7bc2fc10bf75cf84162d09f52e7418","hash":"0747fb149dc2be29da66c633c15dffaf5fcb51effcc061f47d1f0b70c509d93b"}]}